期刊文献+

肝癌组织中环氧化酶-2表达与微小转移的关系研究 被引量:1

Study on relation between the expression of Cox-2 in liver cancer and micro-metastasis
下载PDF
导出
摘要 目的探讨肝癌组织中环氧化酶-2(Cyclooxygenase-2,Cox-2)的表达与肝癌微小转移之间的关系。方法应用免疫组织化学生物素化过氧化物酶复合物(SABC)法,检测44例原发性肝癌手术切除肝癌组织中Cox-2表达;应用逆转录聚合酶链反应(RT-PCR)检测原发性肝癌患者外周血中AFP-mRNA。结果肝癌组织中Cox-2表达阳性率为41.6%(18/44),外周血甲胎蛋白信使核糖核酸(AFP-mRNA)阳性率25%(11/44),其中Cox-2表达阳性者中,AFP-mRNA阳性者为9例,占50%(9/18),而Cox-2表达阴性者中,AFP-mRNA阳性者为2例,占7.7%(2/26),两者有显著性差异。结论肝癌组织中Cox-2表达与肝癌微小转移有相关性。 Objective To explore the relationship between Cox - 2 expression in tissue of liver cancer and micro - metastasis of liver cancer. Methods Forty four patients with primary liver cancer were included in this study. Immunohistochemistry and RT - PCR were used to detect the expression of Cox -2 protein in liver cancer tissue and AFP - mRNA in peripheral blood respectively. Results Cox -2 was positively expressed in 18 of 44 (41.6% ) liver cancer tissues; AFP - mRNA was positively expressed in 11 of 44 ( 25 % ) peripheral blood. AFP - mRNA was positively expressed in 9 of 18 ( 50% ) Cox - 2 positive subjects and 2 of 26 (7.7 % ) Cox - 2 negtive subjects respectively. Significant correlation was found between Cox - 2 expression in tissue and AFP - mRNA expression in peripheral blood. Conclusion The expression of Cox - 2 in the tissues of liver cancer was significantly correlated with metastasis of liver cancer.
作者 邓洪宇
出处 《临床和实验医学杂志》 2007年第10期22-23,共2页 Journal of Clinical and Experimental Medicine
关键词 原发性肝癌 环氧化酶-2 微小转移甲胎蛋白信使核糖核酸 Liver cancer Cyclooxyenase-2 Metastasis AFP- mRNA
  • 相关文献

参考文献1

二级参考文献9

  • 1Yang C,Stephen M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer[J].J Cellular Physiology,2002,190(3):279-286.
  • 2Dohadwala M,Luo J,Zhu L,et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44[J].J Biol Chem,2001,276(24):20809-20812.
  • 3Garcia-Rodriguez L A,Huerta Alvarez C. Reduced risk of colorectal cancer among long-term jusers of aspirin and nonsteroidal antiinflammatory drugs [J].Epidemiology,2001,12(1):88-93.
  • 4Pennisi E. Building a better aspirin[J]. Science,1998,280(5367):1191-1192.
  • 5Oshima M,Dinchuk J E,Kargman S,et al. Suppression of intestinal polyposis in APC△ 716knock out mice by inhibition of cyclooxygenase-2 [J].Cell,1996,87(5):803-809.
  • 6Oshima M,Mural N,Kargman S,et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib,a specific cyclooxygenase-2 inhibitor [J].Cancer Res,2001,61(4):1733-1740.
  • 7Wolff H,Saukkonen K,Anttila S,et al. Expression of cyclooxygenase-2 in human lung carcinoma[J].Cancer Res,1998,58(22):4997-5001.
  • 8Kozaki K,Koshikawa K,Tatematsu Y,et al. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicty og inflammatory cells in metastasis[J].Oncogene, 2001,20(31):4228-4234.
  • 9Achiwa H,Yatabe Y, Hida T,et al. Prognostic significance of elevated cyclooxygenase-2 expression in primary,resected lung adenocarcinomas[J].Clin Cancer Res,1999,5(5):1001-1005.

共引文献2

同被引文献7

  • 1方征东,李建生,徐修才.选择性环氧化酶-2抑制剂对肝癌细胞侵袭力的影响[J].世界华人消化杂志,2006,14(3):293-298. 被引量:5
  • 2Nunez-Martinez O,Clemente-Ricote G, Gareia-Monzon C. Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases[J]. Med Glin (Bare), 2003,121 (19) : 743- 748.
  • 3Kern MA, Schoneweiss MM, Sahi D, et al. Cyclooxygenase-2 inhibitors suppress the growth of human hepatoeel- lular carcinoma implants in nude mice[J]. Carcinogenesis, 2004,25(7) :1193-1199.
  • 4Cheng J, Imanishi H, Liu W, et al. Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellufar carcinoma cell lines[J].Cancer Sci, 2004,95 (8) : 666-673.
  • 5Hu KQ, Yu CH, Mineyama Y, et al. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398,a selective COX 2 inhibitor[J]. Int J Oneol, 2003,22(4) :757- 763.
  • 6Schmidt CM, Wang Y, Wiesenauer C. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepa- tocellular carcinoma provides a synergistic increase in apoptosis[J].J Gastrointest Surg,2003,7(8) : 1024-1033.
  • 7Airbus S, Nakao K, Ichikawa T, et al. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells[J].Hepatology, 2002, 35 (5):1117-1124.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部